West Paces Advisors’s MiMedx Group MDXG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-725
| Closed | -$5.51K | – | 416 |
|
|
2025
Q1 | $5.51K | Hold |
725
| – | – | ﹤0.01% | 379 |
|
|
2024
Q4 | $6.97K | Hold |
725
| – | – | ﹤0.01% | 370 |
|
|
2024
Q3 | $4.29K | Hold |
725
| – | – | ﹤0.01% | 393 |
|
|
2024
Q2 | $5.02K | Hold |
725
| – | – | ﹤0.01% | 391 |
|
|
2024
Q1 | $5.58K | Hold |
725
| – | – | ﹤0.01% | 398 |
|
|
2023
Q4 | $6.36K | Hold |
725
| – | – | ﹤0.01% | 396 |
|
|
2023
Q3 | $5.29K | Hold |
725
| – | – | ﹤0.01% | 392 |
|
|
2023
Q2 | $4.79K | Hold |
725
| – | – | ﹤0.01% | 423 |
|
|
2023
Q1 | $2.47K | Hold |
725
| – | – | ﹤0.01% | 456 |
|
|
2022
Q4 | $2.02K | Hold |
725
| – | – | ﹤0.01% | 435 |
|
|
2022
Q3 | $2.08K | Hold |
725
| – | – | ﹤0.01% | 435 |
|
|
2022
Q2 | $2.52K | Hold |
725
| – | – | ﹤0.01% | 473 |
|
|
2022
Q1 | $3.42K | Hold |
725
| – | – | ﹤0.01% | 448 |
|
|
2021
Q4 | $4.38K | Hold |
725
| – | – | ﹤0.01% | 441 |
|
|
2021
Q3 | $4.39K | Hold |
725
| – | – | ﹤0.01% | 435 |
|
|
2021
Q2 | $9.07K | Hold |
725
| – | – | ﹤0.01% | 367 |
|
|
2021
Q1 | $7.47K | Hold |
725
| – | – | ﹤0.01% | 357 |
|
|
2020
Q4 | $6.58K | Hold |
725
| – | – | ﹤0.01% | 347 |
|
|
2020
Q3 | $4.61K | Hold |
725
| – | – | ﹤0.01% | 365 |
|
|
2020
Q2 | $3.92K | Hold |
725
| – | – | ﹤0.01% | 387 |
|
|
2020
Q1 | $2.53K | Hold |
725
| – | – | ﹤0.01% | 409 |
|
|
2019
Q4 | $5.5K | Hold |
725
| – | – | ﹤0.01% | 397 |
|
|
2019
Q3 | $3.55K | Hold |
725
| – | – | ﹤0.01% | 408 |
|
|
2019
Q2 | $2.94K | Hold |
725
| – | – | ﹤0.01% | 419 |
|
|
2019
Q1 | $2.54K | Hold |
725
| – | – | ﹤0.01% | 426 |
|
|
2018
Q4 | $1.3K | Hold |
725
| – | – | ﹤0.01% | 457 |
|
|
2018
Q3 | $4.48K | Hold |
725
| – | – | ﹤0.01% | 394 |
|
|
2018
Q2 | $4.63K | Hold |
725
| – | – | ﹤0.01% | 392 |
|
|
2018
Q1 | $5.05K | Hold |
725
| – | – | ﹤0.01% | 367 |
|
|
2017
Q4 | $9.14K | Hold |
725
| – | – | 0.01% | 347 |
|
|
2017
Q3 | $8.61K | Hold |
725
| – | – | 0.01% | 348 |
|
|
2017
Q2 | $10.9K | Hold |
725
| – | – | 0.01% | 322 |
|
|
2017
Q1 | $6.91K | Hold |
725
| – | – | 0.01% | 363 |
|
|
2016
Q4 | $6.42K | Buy |
+725
| New | +$6.51K | 0.01% | 387 |
|
Other funds holding MDXG
EWM
TI
CC
West Paces Advisors's MDXG Position: Q2 2025 in Review
West Paces Advisors sold out of MiMedx Group (MDXG) in Q2 2025, closing a stake of 725 shares — an estimated $5.51K sold.
West Paces Advisors first reported a position in MDXG in Q4 2016 and held it in 34 quarters. The position peaked at $10.9K in Q2 2017. 223 funds tracked by Wall St. Rank hold MDXG as of Q2 2025.
- West Paces Advisors reported no remaining MiMedx Group position as of Q2 2025 after selling out during the quarter.
- West Paces Advisors sold 725 MiMedx Group shares in Q2 2025, an estimated $5.51K.
- West Paces Advisors first reported a position in MiMedx Group in Q4 2016 and held it in 34 quarters.
- West Paces Advisors's MiMedx Group position peaked at $10.9K in Q2 2017.
- 223 funds tracked by Wall St. Rank held MiMedx Group as of Q2 2025.
Based on West Paces Advisors's 13F filing for Q2 2025, filed 23 Jul 2025.